» Articles » PMID: 16505370

The Colorectal MicroRNAome

Abstract

MicroRNAs (miRNAs) are a class of small noncoding RNAs that have important regulatory roles in multicellular organisms. The public miRNA database contains 321 human miRNA sequences, 234 of which have been experimentally verified. To explore the possibility that additional miRNAs are present in the human genome, we have developed an experimental approach called miRNA serial analysis of gene expression (miRAGE) and used it to perform the largest experimental analysis of human miRNAs to date. Sequence analysis of 273,966 small RNA tags from human colorectal cells allowed us to identify 200 known mature miRNAs, 133 novel miRNA candidates, and 112 previously uncharacterized miRNA* forms. To aid in the evaluation of candidate miRNAs, we disrupted the Dicer locus in three human colorectal cancer cell lines and examined known and novel miRNAs in these cells. These studies suggest that the human genome contains many more miRNAs than currently identified and provide an approach for the large-scale experimental cloning of novel human miRNAs in human tissues.

Citing Articles

Butyrate Metabolism-Related Gene Signature in Tumor Immune Microenvironment in Lung Adenocarcinoma: A Comprehensive Bioinformatics Study.

Zhao J, Wang X, Wang J, You Y, Wang Q, Xu Y Immun Inflamm Dis. 2024; 12(12):e70087.

PMID: 39641239 PMC: 11621860. DOI: 10.1002/iid3.70087.


miR-617 interacts with the promoter of and positively regulates its expression: implications for cancer therapeutics.

Sarkar N, Mishra R, Gopal C, Kumar A Front Oncol. 2024; 14:1411539.

PMID: 38939334 PMC: 11208480. DOI: 10.3389/fonc.2024.1411539.


Restricting Colorectal Cancer Cell Metabolism with Metformin: An Integrated Transcriptomics Study.

Orang A, Marri S, McKinnon R, Petersen J, Michael M Cancers (Basel). 2024; 16(11).

PMID: 38893174 PMC: 11171104. DOI: 10.3390/cancers16112055.


Gene polymorphisms of TACR1 serve as the potential pharmacogenetic predictors of response to the neurokinin-1 receptor antagonist-based antiemetic regimens: a candidate-gene association study in breast cancer patients.

Ghorbani M, Namazi S, Dehghani M, Razi F, Khalvati B, Dehshahri A Cancer Chemother Pharmacol. 2024; 94(2):237-250.

PMID: 38678150 DOI: 10.1007/s00280-024-04661-9.


Fibre-rich Foods to Treat Obesity and Prevent Colon Cancer trial study protocol: a randomised clinical trial of fibre-rich legumes targeting the gut microbiome, metabolome and gut transit time of overweight and obese patients with a history of....

Hartman T, Christie J, Wilson A, Ziegler T, Methe B, Flanders W BMJ Open. 2024; 14(2):e081379.

PMID: 38316601 PMC: 10860035. DOI: 10.1136/bmjopen-2023-081379.


References
1.
Bernstein E, Caudy A, Hammond S, Hannon G . Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001; 409(6818):363-6. DOI: 10.1038/35053110. View

2.
Mathews D, Sabina J, Zuker M, Turner D . Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol. 1999; 288(5):911-40. DOI: 10.1006/jmbi.1999.2700. View

3.
Lau N, Lim L, WEINSTEIN E, Bartel D . An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001; 294(5543):858-62. DOI: 10.1126/science.1065062. View

4.
Lee R, Ambros V . An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001; 294(5543):862-4. DOI: 10.1126/science.1065329. View

5.
Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L . miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 2002; 16(6):720-8. PMC: 155365. DOI: 10.1101/gad.974702. View